Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

2%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 20mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

2%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 20mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

1%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 10mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

1%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 10mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

1%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 10mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

1%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 10mg/1ml

Inggris - Inggris - MHRA (Medicines & Healthcare Products Regulatory Agency)

0.5%) solution for injection ampoules (advanz pharma - lidocaine hydrochloride - solution for injection - 5mg/1ml

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - naloxone hydrochloride dihydrate, quantity: 440 microgram (equivalent: naloxone hydrochloride?, qty 400 microgram) - injection - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - narcan is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and the narcotic antagonist analgesics: nalbuphine, pentazocine and butorphanol. narcan is also indicated for the diagnosis of suspected acute opioid overdosage.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - midazolam hydrochloride, quantity: 5.56 mg/ml (equivalent: midazolam, qty 5 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

b braun australia pty ltd - midazolam hydrochloride, quantity: 1.112 mg/ml (equivalent: midazolam, qty 1 mg/ml) - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - iv as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic; iv for induction of anaesthesia, preliminary to administration of other anaesthetic agents. with the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time; iv for sedation in intensive care units; intermittent administration or continuous infusion; im for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.